Current progress in immunotherapy of hepatocellular carcinoma

被引：46

作者：

Sprinzl, Martin F. ^{[1
]}

Galle, Peter R. ^{[1
]}

机构：

[1] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, Langenbeckstr 1, D-55131 Mainz, Germany

来源：

JOURNAL OF HEPATOLOGY | 2017年 / 66卷 / 03期

关键词：

Liver cancer; Therapy; Immunotherapy; Checkpoint inhibitors; REGULATORY T-CELLS; THERMAL ABLATION; DOCETAXEL; BLOCKADE; NIVOLUMAB; PD-L1;

D O I：

10.1016/j.jhep.2016.12.009

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：482 / 484

页数：3

共 19 条

[1] Activation of dendritic cells by local ablation of hepatocellular carcinoma [J].

Ali, MY ;

Grimm, CF ;

Ritter, M ;

Mohr, L ;

Allgaier, HP ;

Weth, R ;

Bocher, WO ;

Endrulat, K ;

Blum, HE ;

Geissler, M .

JOURNAL OF HEPATOLOGY, 2005, 43 (05) :817-822

[2] Nivolumab versus Docetaxel in Advanced Nonsquamous Non-Small-Cell Lung Cancer [J].

Borghaei, H. ;

Paz-Ares, L. ;

Horn, L. ;

Spigel, D. R. ;

Steins, M. ;

Ready, N. E. ;

Chow, L. Q. ;

Vokes, E. E. ;

Felip, E. ;

Holgado, E. ;

Barlesi, F. ;

Kohlhaeufl, M. ;

Arrieta, O. ;

Burgio, M. A. ;

Fayette, J. ;

Lena, H. ;

Poddubskaya, E. ;

Gerber, D. E. ;

Gettinger, S. N. ;

Rudin, C. M. ;

Rizvi, N. ;

Crino, L. ;

Blumenschein, G. R. ;

Antonia, S. J. ;

Dorange, C. ;

Harbison, C. T. ;

Finckenstein, F. Graf ;

Brahmer, J. R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (17) :1627-1639

[3] Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J].

Brahmer, Julie ;

Reckamp, Karen L. ;

Baas, Paul ;

Crino, Lucio ;

Eberhardt, Wilfried E. E. ;

Poddubskaya, Elena ;

Antonia, Scott ;

Pluzanski, Adam ;

Vokes, Everett E. ;

Holgado, Esther ;

Waterhouse, David ;

Ready, Neal ;

Gainor, Justin ;

Aren Frontera, Osvaldo ;

Havel, Libor ;

Steins, Martin ;

Garassino, Marina C. ;

Aerts, Joachim G. ;

Domine, Manuel ;

Paz-Ares, Luis ;

Reck, Martin ;

Baudelet, Christine ;

Harbison, Christopher T. ;

Lestini, Brian ;

Spigel, David R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (02) :123-135

[4] Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T [J].

Burga, Rachel A. ;

Thorn, Mitchell ;

Point, Gary R. ;

Guha, Prajna ;

Nguyen, Cang T. ;

Licata, Lauren A. ;

DeMatteo, Ronald P. ;

Ayala, Alfred ;

Espat, N. Joseph ;

Junghans, Richard P. ;

Katz, Steven C. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2015, 64 (07) :817-829

[5] Programmed Death Ligand 1 Expression in Hepatocellular Carcinoma: Relationship With Clinical and Pathological Features [J].

Calderaro, Julien ;

Rousseau, Benoit ;

Amaddeo, Giuliana ;

Mercey, Marion ;

Charpy, Cecile ;

Costentin, Charlotte ;

Luciani, Alain ;

Zafrani, Elie-Serge ;

Laurent, Alexis ;

Azoulay, Daniel ;

Lafdil, Fouad ;

Pawlotsky, Jean-Michel .

HEPATOLOGY, 2016, 64 (06) :2038-2046

[6] Thermal ablation of tumours: biological mechanisms and advances in therapy [J].

Chu, Katrina F. ;

Dupuy, Damian E. .

NATURE REVIEWS CANCER, 2014, 14 (03) :199-208

[7] Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma [J].

Duffy, Austin G. ;

Ulahannan, Susanna V. ;

Makorova-Rusher, Oxana ;

Rahma, Osama ;

Wedemeyer, Heiner ;

Pratt, Drew ;

Davis, Jeremy L. ;

Hughes, Marybeth S. ;

Heller, Theo ;

ElGindi, Mei ;

Uppala, Ashish ;

Korangy, Firouzeh ;

Kleiner, David E. ;

Figg, William D. ;

Venzon, David ;

Steinberg, Seth M. ;

Venkatesan, Aradhana M. ;

Krishnasamy, Venkatesh ;

Abi-Jaoudeh, Nadine ;

Levy, Elliot ;

Wood, Brad J. ;

Greten, Tim F. .

JOURNAL OF HEPATOLOGY, 2017, 66 (03) :545-551

[8] Image-guided Thermal Ablation of Tumors Increases the Plasma Level of Interleukin-6 and Interleukin-10 [J].

Erinjeri, Joseph P. ;

Thomas, Contessa T. ;

Samoilia, Alaiksandra ;

Fleisher, Martin ;

Gonen, Mithat ;

Sofocleous, Constantinos T. ;

Thornton, Raymond H. ;

Siegelbaum, Robert H. ;

Covey, Anne M. ;

Brody, Lynn A. ;

Alago, William, Jr. ;

Maybody, Majid ;

Brown, Karen T. ;

Getrajdman, George I. ;

Solomon, Stephen B. .

JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 2013, 24 (08) :1105-1112

[9] Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial [J].

Fehrenbacher, Louis ;

Spira, Alexander ;

Ballinger, Marcus ;

Kowanetz, Marcin ;

Vansteenkiste, Johan ;

Mazieres, Julien ;

Park, Keunchil ;

Smith, David ;

Artal-Cortes, Angel ;

Lewanski, Conrad ;

Braiteh, Fadi ;

Waterkamp, Daniel ;

He, Pei ;

Zou, Wei ;

Chen, Daniel S. ;

Yi, Jing ;

Sandler, Alan ;

Rittmeyer, Achim .

LANCET, 2016, 387 (10030) :1837-1846

[10] Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial [J].

Herbst, Roy S. ;

Baas, Paul ;

Kim, Dong-Wan ;

Felip, Enriqueta ;

Perez-Gracia, Jose L. ;

Han, Ji-Youn ;

Molina, Julian ;

Kim, Joo-Hang ;

Arvis, Catherine Dubos ;

Ahn, Myung-Ju ;

Majem, Margarita ;

Fidler, Mary J. ;

de Castro, Gilberto, Jr. ;

Garrido, Marcelo ;

Lubiniecki, Gregory M. ;

Shentu, Yue ;

Im, Ellie ;

Dolled-Filhart, Marisa ;

Garon, Edward B. .

LANCET, 2016, 387 (10027) :1540-1550

← 1 2 →